{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:35:50Z","timestamp":1752982550646,"version":"3.40.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["54\/13\/2022-HUM\/BMS"],"award-info":[{"award-number":["54\/13\/2022-HUM\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Intercellular communication is a critical process that ensures cooperation between distinct cell types and maintains homeostasis. In the past decades, extracellular vesicles (EVs) have been recognized as key components in cell-to-cell communication. These EVs carry multiple factors such as active enzymes, metabolites, nucleic acids and surface molecules that can alter the behavior of recipient cells. Thus, the role of EVs in exacerbating disease pathology by transporting inflammatory mediators, and other molecular signals that contribute to chronic inflammation and immune dysregulation in various diseases including cystic fibrosis (CF) is well documented.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main body<\/jats:title>\n            <jats:p>CF is a genetic disorder characterized by chronic inflammation and persistent infections, primarily affecting the respiratory system. This review explores the multifaceted roles of EVs in CF lung disease, focusing on their biogenesis, cargo, and contributions to disease progression. It is well known that CF results from mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, leading to defective ion transport, thick mucus secretion, and a propensity for bacterial infections. However, it has been observed that EVs derived from CF patients carry altered molecular cargo, including proteins, lipids, RNA, and DNA, which can exacerbate these conditions by promoting inflammation, and modulating immune responses. Beyond their pathogenic roles, EVs also hold significant therapeutic potential. Their natural ability to transfer bioactive molecules positions them as promising vectors for delivering therapeutic agents, such as gene therapy constructs and anti-inflammatory compounds. Accordingly, a study has shown that these EVs can act as a carrier molecule for transport of functional CFTR mRNA, helping to restore proper chloride ion channel function by correcting defective CFTR proteins in affected cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This review aims to summarize the role of EVs and their molecular cargo in pathogenesis of CF lung disease via modulation of intracellular signaling leading to persistent inflammation and increased disease severity. We also explored the mechanisms of EV biogenesis, cargo selection, and their effects on recipient cells which may provide novel insights into CF pathogenesis and open new avenues for EV-based therapies aimed at improving disease management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40348-025-00190-4","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T06:48:01Z","timestamp":1745218081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding the role of extracellular vesicles in pathogenesis of cystic fibrosis"],"prefix":"10.1186","volume":"12","author":[{"given":"Priya","family":"Kalsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitanjali","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2236-7156","authenticated-orcid":false,"given":"Himanshu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"190_CR1","doi-asserted-by":"crossref","unstructured":"Hanssens LS, Duchateau J, Casimir GJ (2021) Cftr protein: not just a chloride channel? Cells 10","DOI":"10.3390\/cells10112844"},{"key":"190_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009498","author":"TC Hwang","year":"2013","unstructured":"Hwang TC, Kirk KL (2013) The CFTR ion channel: Gating, regulation, and anion permeation. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a009498. 3:","journal-title":"Cold Spring Harb Perspect Med"},{"key":"190_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/pharmaceutics12070616","volume":"12","author":"FA Almughem","year":"2020","unstructured":"Almughem FA, Aldossary AM, Tawfik EA et al (2020) Cystic fibrosis: overview of the current development trends and innovative therapeutic strategies. Pharmaceutics 12:616. https:\/\/doi.org\/10.3390\/pharmaceutics12070616","journal-title":"Pharmaceutics"},{"key":"190_CR4","doi-asserted-by":"publisher","unstructured":"Di Gioia S, Daniello V, Conese M (2022) Extracellular vesicles\u2019 role in the pathophysiology and as biomarkers in cystic fibrosis and COPD. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24010228","DOI":"10.3390\/ijms24010228"},{"key":"190_CR5","unstructured":"Cystic Fibrosis mutation database, CFMDB Statistics"},{"key":"190_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/thoraxjnl-2019-214027","volume":"75","author":"Z Useckaite","year":"2020","unstructured":"Useckaite Z, Ward MP, Trappe A et al (2020) Increased extracellular vesicles mediate inflammatory signalling in cystic fibrosis. Thorax 75:449\u2013458. https:\/\/doi.org\/10.1136\/thoraxjnl-2019-214027","journal-title":"Thorax"},{"key":"190_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ et al (2024) Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther 9:27. https:\/\/doi.org\/10.1038\/s41392-024-01735-1","journal-title":"Signal Transduct Target Ther"},{"key":"190_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1183\/09031936.03.00041703","volume":"22","author":"C Admyre","year":"2003","unstructured":"Admyre C, Grunewald J, Thyberg J et al (2003) Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur Respir J 22:578\u2013583. https:\/\/doi.org\/10.1183\/09031936.03.00041703","journal-title":"Eur Respir J"},{"key":"190_CR9","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/CM9.0000000000002118","volume":"135","author":"L Zhou","year":"2022","unstructured":"Zhou L, Luo H, Lee JW (2022) Role of extracellular vesicles in lung diseases. Chin Med J (Engl) 135:1765\u20131780. https:\/\/doi.org\/10.1097\/CM9.0000000000002118","journal-title":"Chin Med J (Engl)"},{"key":"190_CR10","doi-asserted-by":"publisher","unstructured":"Mir B, Goettsch C (2020) Extracellular vesicles as delivery vehicles of specific cellular cargo. Cells 9. https:\/\/doi.org\/10.3390\/cells9071601","DOI":"10.3390\/cells9071601"},{"key":"190_CR11","doi-asserted-by":"crossref","unstructured":"Zareba L, Szymanski J, Homoncik Z, Czystowska-Kuzmicz M (2021) Evs from balf\u2014mediators of inflammation and potential biomarkers in lung diseases. Int J Mol Sci 22","DOI":"10.3390\/ijms22073651"},{"key":"190_CR12","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jacbts.2017.08.004","volume":"2","author":"F Jansen","year":"2017","unstructured":"Jansen F, Li Q, Pfeifer A, Werner N (2017) Endothelial- and immune Cell-Derived extracellular vesicles in the regulation of cardiovascular health and disease. JACC Basic Transl Sci 2:790\u2013807. https:\/\/doi.org\/10.1016\/j.jacbts.2017.08.004","journal-title":"JACC Basic Transl Sci"},{"key":"190_CR13","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.7150\/thno.20576","volume":"8","author":"M Rodrigues","year":"2018","unstructured":"Rodrigues M, Fan J, Lyon C et al (2018) Role of extracellular vesicles in viral and bacterial infections: pathogenesis, diagnostics, and therapeutics. Theranostics 8:2709\u20132721. https:\/\/doi.org\/10.7150\/thno.20576","journal-title":"Theranostics"},{"key":"190_CR14","doi-asserted-by":"publisher","first-page":"184219","DOI":"10.1016\/j.bbamem.2023.184219","volume":"1866","author":"MA Al-Humiari","year":"2024","unstructured":"Al-Humiari MA, Yu L, Liu LP et al (2024) Extracellular vesicles from BALF of pediatric cystic fibrosis and asthma patients increase epithelial sodium channel activity in small airway epithelial cells. Biochim Biophys Acta Biomembr 1866:184219. https:\/\/doi.org\/10.1016\/j.bbamem.2023.184219","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"190_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jprot.2018.07.001","volume":"185","author":"V Rollet-Cohen","year":"2018","unstructured":"Rollet-Cohen V, Bourderioux M, Lipecka J et al (2018) Comparative proteomics of respiratory exosomes in cystic fibrosis, primary ciliary dyskinesia and asthma. J Proteom 185:1\u20137. https:\/\/doi.org\/10.1016\/j.jprot.2018.07.001","journal-title":"J Proteom"},{"key":"190_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/JLB.3AB0321-149R","volume":"112","author":"OA Forrest","year":"2022","unstructured":"Forrest OA, Dobosh B, Ingersoll SA et al (2022) Neutrophil-derived extracellular vesicles promote feed-forward inflammasome signaling in cystic fibrosis airways. J Leukoc Biol 112:707\u2013716. https:\/\/doi.org\/10.1002\/JLB.3AB0321-149R","journal-title":"J Leukoc Biol"},{"key":"190_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fcell.2017.00039","volume":"5","author":"CJE Wahlund","year":"2017","unstructured":"Wahlund CJE, Eklund A, Grunewald J, Gabrielsson S (2017) Pulmonary extracellular vesicles as mediators of local and systemic inflammation. Front Cell Dev Biol 5:39. https:\/\/doi.org\/10.3389\/fcell.2017.00039","journal-title":"Front Cell Dev Biol"},{"key":"190_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1542\/pir.2019-0212","volume":"42","author":"KM Dickinson","year":"2021","unstructured":"Dickinson KM, Collaco JM (2021) Cystic fibrosis. Pediatr Rev 42:55\u201367. https:\/\/doi.org\/10.1542\/pir.2019-0212","journal-title":"Pediatr Rev"},{"key":"190_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/humu.10041","volume":"19","author":"JL Bobadilla","year":"2002","unstructured":"Bobadilla JL, Macek M, Fine JP, Farrell PM (2002) Cystic fibrosis: A worldwide analysis OfCFTR mutations?correlation with incidence data and application to screening. Hum Mutat 19:575\u2013606. https:\/\/doi.org\/10.1002\/humu.10041","journal-title":"Hum Mutat"},{"key":"190_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.molmed.2011.10.003","volume":"18","author":"GL Lukacs","year":"2012","unstructured":"Lukacs GL, Verkman AS (2012) CFTR: folding, misfolding and correcting the \u2206F508 conformational defect. Trends Mol Med 18:81\u201391. https:\/\/doi.org\/10.1016\/j.molmed.2011.10.003","journal-title":"Trends Mol Med"},{"key":"190_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1046\/j.1523-1755.2000.00921.x","volume":"57","author":"WR Skach","year":"2000","unstructured":"Skach WR (2000) Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator. Kidney Int 57:825\u2013831. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00921.x","journal-title":"Kidney Int"},{"key":"190_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1055\/s-0039-1694021","volume":"40","author":"C Bergeron","year":"2019","unstructured":"Bergeron C, Cantin AM (2019) Cystic fibrosis: pathophysiology of lung disease. Semin Respir Crit Care Med 40:715\u2013726. https:\/\/doi.org\/10.1055\/s-0039-1694021","journal-title":"Semin Respir Crit Care Med"},{"key":"190_CR23","doi-asserted-by":"publisher","first-page":"e01536","DOI":"10.1128\/mBio.01536-14","volume":"5","author":"SC Chew","year":"2014","unstructured":"Chew SC, Kundukad B, Seviour T et al (2014) Dynamic remodeling of microbial biofilms by functionally distinct exopolysaccharides. mBio 5:e01536\u2013e01514. https:\/\/doi.org\/10.1128\/mBio.01536-14","journal-title":"mBio"},{"key":"190_CR24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archpediatrics.2011.136","volume":"165","author":"MM Treggiari","year":"2011","unstructured":"Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N et al (2011) Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med 165:847\u2013856. https:\/\/doi.org\/10.1001\/archpediatrics.2011.136","journal-title":"Arch Pediatr Adolesc Med"},{"key":"190_CR25","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1016\/j.crad.2013.10.023","volume":"69","author":"MY Ng","year":"2014","unstructured":"Ng MY, Flight W, Smith E (2014) Pulmonary complications of cystic fibrosis. Clin Radiol 69:e153\u2013e162. https:\/\/doi.org\/10.1016\/j.crad.2013.10.023","journal-title":"Clin Radiol"},{"key":"190_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12951-023-01921-3","volume":"21","author":"J Zhu","year":"2023","unstructured":"Zhu J, Wang S, Yang D et al (2023) Extracellular vesicles: emerging roles, biomarkers and therapeutic strategies in fibrotic diseases. J Nanobiotechnol 21:164. https:\/\/doi.org\/10.1186\/s12951-023-01921-3","journal-title":"J Nanobiotechnol"},{"key":"190_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10571-016-0366-z","volume":"36","author":"ER Abels","year":"2016","unstructured":"Abels ER, Breakefield XO (2016) Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake. Cell Mol Neurobiol 36:301\u2013312. https:\/\/doi.org\/10.1007\/s10571-016-0366-z","journal-title":"Cell Mol Neurobiol"},{"key":"190_CR28","doi-asserted-by":"publisher","unstructured":"Hadizadeh N, Bagheri D, Shamsara M et al (2022) Extracellular vesicles biogenesis, isolation, manipulation and genetic engineering for potential in vitro and in vivo therapeutics: an overview. Front Bioeng Biotechnol 10. https:\/\/doi.org\/10.3389\/fbioe.2022.1019821","DOI":"10.3389\/fbioe.2022.1019821"},{"key":"190_CR29","doi-asserted-by":"publisher","unstructured":"Chiaradia E, Tancini B, Emiliani C et al (2021) Extracellular vesicles under oxidative stress conditions: biological properties and physiological roles. https:\/\/doi.org\/10.3390\/cells10071763. Cells 10:","DOI":"10.3390\/cells10071763"},{"key":"190_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Liu Y, Liu H, Tang WH (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9:19. https:\/\/doi.org\/10.1186\/s13578-019-0282-2","journal-title":"Cell Biosci"},{"key":"190_CR31","doi-asserted-by":"crossref","unstructured":"Kang T, Atukorala I, Mathivanan S (2021) Biogenesis of Extracellular Vesicles. pp 19\u201343","DOI":"10.1007\/978-3-030-67171-6_2"},{"key":"190_CR32","first-page":"66","volume":"17","author":"A Asef","year":"2018","unstructured":"Asef A, Mortaz E, Jamaati H, Velayati A (2018) Immunologic role of extracellular vesicles and exosomes in the pathogenesis of cystic fibrosis. Tanaffos 17:66\u201372","journal-title":"Tanaffos"},{"key":"190_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.biocel.2014.03.006","volume":"52","author":"AG Ziady","year":"2014","unstructured":"Ziady AG, Hansen J (2014) Redox balance in cystic fibrosis. Int J Biochem Cell Biol 52:113\u2013123. https:\/\/doi.org\/10.1016\/j.biocel.2014.03.006","journal-title":"Int J Biochem Cell Biol"},{"key":"190_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/hum.2015.144","volume":"27","author":"C Vituret","year":"2016","unstructured":"Vituret C, Gallay K, Confort M-P et al (2016) Transfer of the cystic fibrosis transmembrane conductance regulator to human cystic fibrosis cells mediated by extracellular vesicles. Hum Gene Ther 27:166\u2013183. https:\/\/doi.org\/10.1089\/hum.2015.144","journal-title":"Hum Gene Ther"},{"key":"190_CR35","doi-asserted-by":"publisher","first-page":"L54","DOI":"10.1152\/ajplung.00150.2022","volume":"325","author":"K Koeppen","year":"2023","unstructured":"Koeppen K, Hampton TH, Barnaby R et al (2023) An rRNA fragment in extracellular vesicles secreted by human airway epithelial cells increases the fluoroquinolone sensitivity of P. aeruginosa. Am J Physiol Lung Cell Mol Physiol 325:L54\u2013L65. https:\/\/doi.org\/10.1152\/ajplung.00150.2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"190_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/MMBR.00031-09","volume":"74","author":"TN Ellis","year":"2010","unstructured":"Ellis TN, Kuehn MJ (2010) Virulence and Immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 74:81\u201394. https:\/\/doi.org\/10.1128\/MMBR.00031-09","journal-title":"Microbiol Mol Biol Rev"},{"key":"190_CR37","doi-asserted-by":"publisher","first-page":"e1000382","DOI":"10.1371\/journal.ppat.1000382","volume":"5","author":"JM Bomberger","year":"2009","unstructured":"Bomberger JM, MacEachran DP, Coutermarsh BA et al (2009) Long-Distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog 5:e1000382. https:\/\/doi.org\/10.1371\/journal.ppat.1000382","journal-title":"PLoS Pathog"},{"key":"190_CR38","doi-asserted-by":"publisher","unstructured":"Garcia-Clemente M, de la Rosa D, M\u00e1iz L et al (2020) Impact of Pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases. J Clin Med 9. https:\/\/doi.org\/10.3390\/jcm9123800","DOI":"10.3390\/jcm9123800"},{"key":"190_CR39","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1099\/mic.0.26841-0","volume":"150","author":"M Renelli","year":"2004","unstructured":"Renelli M, Matias V, Lo RY, Beveridge TJ (2004) DNA-containing membrane vesicles of Pseudomonas aeruginosa PAO1 and their genetic transformation potential. Microbiol (N Y) 150:2161\u20132169. https:\/\/doi.org\/10.1099\/mic.0.26841-0","journal-title":"Microbiol (N Y)"},{"key":"190_CR40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4049\/immunohorizons.2000026","volume":"4","author":"DA Armstrong","year":"2020","unstructured":"Armstrong DA, Lee MK, Hazlett HF et al (2020) Extracellular vesicles from Pseudomonas aeruginosa suppress MHC-Related molecules in human lung macrophages. Immunohorizons 4:508\u2013519. https:\/\/doi.org\/10.4049\/immunohorizons.2000026","journal-title":"Immunohorizons"},{"key":"190_CR41","doi-asserted-by":"publisher","first-page":"e0211290","DOI":"10.1371\/journal.pone.0211290","volume":"14","author":"K Koeppen","year":"2019","unstructured":"Koeppen K, Barnaby R, Jackson AA et al (2019) Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles. PLoS ONE 14:e0211290. https:\/\/doi.org\/10.1371\/journal.pone.0211290","journal-title":"PLoS ONE"},{"key":"190_CR42","doi-asserted-by":"publisher","unstructured":"Cecil JD, Sirisaengtaksin N, O\u2019Brien-Simpson NM, Krachler AM (2019) Outer membrane Vesicle-Host cell interactions. Microbiol Spectr 7. https:\/\/doi.org\/10.1128\/microbiolspec.PSIB-0001-2018","DOI":"10.1128\/microbiolspec.PSIB-0001-2018"},{"key":"190_CR43","doi-asserted-by":"publisher","first-page":"108672","DOI":"10.1016\/j.celrep.2020.108672","volume":"34","author":"MR Hendricks","year":"2021","unstructured":"Hendricks MR, Lane S, Melvin JA et al (2021) Extracellular vesicles promote transkingdom nutrient transfer during viral-bacterial co-infection. Cell Rep 34:108672. https:\/\/doi.org\/10.1016\/j.celrep.2020.108672","journal-title":"Cell Rep"},{"key":"190_CR44","first-page":"1","volume":"2","author":"B Moldoveanu","year":"2009","unstructured":"Moldoveanu B, Otmishi P, Jani P et al (2009) Inflammatory mechanisms in the lung. J Inflamm Res 2:1\u201311","journal-title":"J Inflamm Res"},{"key":"190_CR45","doi-asserted-by":"publisher","unstructured":"Petrocheilou A, Moudaki A, Kaditis AG (2022) Inflammation and infection in cystic fibrosis: update for the clinician. Child (Basel) 9. https:\/\/doi.org\/10.3390\/children9121898","DOI":"10.3390\/children9121898"},{"key":"190_CR46","doi-asserted-by":"publisher","unstructured":"Esther CR, Muhlebach MS, Ehre C et al (2019) Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis. Sci Transl Med 11. https:\/\/doi.org\/10.1126\/scitranslmed.aav3488","DOI":"10.1126\/scitranslmed.aav3488"},{"key":"190_CR47","doi-asserted-by":"publisher","unstructured":"Montgomery ST, Mall MA, Kicic A et al (2017) Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies. Eur Respir J 49. https:\/\/doi.org\/10.1183\/13993003.00903-2016","DOI":"10.1183\/13993003.00903-2016"},{"key":"190_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22041952","volume":"22","author":"A Ghigo","year":"2021","unstructured":"Ghigo A, Prono G, Riccardi E, De Rose V (2021) Dysfunctional inflammation in cystic fibrosis airways: from mechanisms to novel therapeutic approaches. Int J Mol Sci 22:1\u201323","journal-title":"Int J Mol Sci"},{"key":"190_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ni.3045","volume":"16","author":"JA Whitsett","year":"2015","unstructured":"Whitsett JA, Alenghat T (2015) Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol 16:27\u201335. https:\/\/doi.org\/10.1038\/ni.3045","journal-title":"Nat Immunol"},{"key":"190_CR50","doi-asserted-by":"publisher","unstructured":"Biswas R, Kumar P, Pollard HB (2017) Regulation of <\u2009scp\u2009>\u2009mrna\u2009turnover in cystic fibrosis lung disease. https:\/\/doi.org\/10.1002\/wrna.1408. WIREs RNA 8:","DOI":"10.1002\/wrna.1408"},{"key":"190_CR51","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/gt.2015.56","volume":"22","author":"P Kumar","year":"2015","unstructured":"Kumar P, Bhattacharyya S, Peters KW et al (2015) miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells. Gene Ther 22:908\u2013916. https:\/\/doi.org\/10.1038\/gt.2015.56","journal-title":"Gene Ther"},{"key":"190_CR52","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1074\/jbc.M110.198390","volume":"286","author":"S Bhattacharyya","year":"2011","unstructured":"Bhattacharyya S, Balakathiresan NS, Dalgard C et al (2011) Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of Interleukin-8. J Biol Chem 286:11604\u201311615. https:\/\/doi.org\/10.1074\/jbc.M110.198390","journal-title":"J Biol Chem"},{"key":"190_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1089\/jir.2012.0074","volume":"33","author":"M Tsuchiya","year":"2013","unstructured":"Tsuchiya M, Kumar P, Bhattacharyya S et al (2013) Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells. J Interferon Cytokine Res 33:121\u2013129. https:\/\/doi.org\/10.1089\/jir.2012.0074","journal-title":"J Interferon Cytokine Res"},{"key":"190_CR54","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/diagnostics10121102","volume":"10","author":"FDE De Palma","year":"2020","unstructured":"De Palma FDE, Raia V, Kroemer G, Maiuri MC (2020) The multifaceted roles of MicroRNAs in cystic fibrosis. Diagnostics 10:1102. https:\/\/doi.org\/10.3390\/diagnostics10121102","journal-title":"Diagnostics"},{"key":"190_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/biom3010157","volume":"3","author":"C Greene","year":"2013","unstructured":"Greene C (2013) MicroRNA expression in cystic fibrosis airway epithelium. Biomolecules 3:157\u2013167. https:\/\/doi.org\/10.3390\/biom3010157","journal-title":"Biomolecules"},{"key":"190_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1042\/BST20170469","volume":"46","author":"AMA Glasgow","year":"2018","unstructured":"Glasgow AMA, De Santi C, Greene CM (2018) Non-coding RNA in cystic fibrosis. Biochem Soc Trans 46:619\u2013630. https:\/\/doi.org\/10.1042\/BST20170469","journal-title":"Biochem Soc Trans"},{"key":"190_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1465-9921-11-148","volume":"11","author":"IK Oglesby","year":"2010","unstructured":"Oglesby IK, McElvaney NG, Greene CM (2010) MicroRNAs in inflammatory lung disease\u2013master regulators or target practice? Respir Res 11:148. https:\/\/doi.org\/10.1186\/1465-9921-11-148","journal-title":"Respir Res"},{"key":"190_CR58","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1183\/09031936.00163414","volume":"46","author":"IK Oglesby","year":"2015","unstructured":"Oglesby IK, Vencken SF, Agrawal R et al (2015) miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production. Eur Respir J 46:1350\u20131360. https:\/\/doi.org\/10.1183\/09031936.00163414","journal-title":"Eur Respir J"},{"key":"190_CR59","doi-asserted-by":"publisher","unstructured":"McKiernan PJ, Greene CM (2015) MicroRNA dysregulation in cystic fibrosis. Mediators Inflamm 2015(529642). https:\/\/doi.org\/10.1155\/2015\/529642","DOI":"10.1155\/2015\/529642"},{"key":"190_CR60","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.3390\/cells10102663","volume":"10","author":"R Sanwlani","year":"2021","unstructured":"Sanwlani R, Gangoda L (2021) Role of extracellular vesicles in cell death and inflammation. Cells 10:2663. https:\/\/doi.org\/10.3390\/cells10102663","journal-title":"Cells"},{"key":"190_CR61","doi-asserted-by":"publisher","unstructured":"Das K, Paul S, Mukherjee T et al (2023) Beyond macromolecules: extracellular vesicles as regulators of inflammatory diseases. https:\/\/doi.org\/10.3390\/cells12151963. Cells 12:","DOI":"10.3390\/cells12151963"},{"key":"190_CR62","doi-asserted-by":"crossref","unstructured":"Takagi K, Yamakuchi M, Hashiguchi T, Inoue H (2019) The Role of miRNAs in Idiopathic Pulmonary Fibrosis. In: Interstitial Lung Diseases. IntechOpen","DOI":"10.5772\/intechopen.82771"},{"key":"190_CR63","doi-asserted-by":"publisher","first-page":"026005","DOI":"10.1088\/1752-7163\/acb792","volume":"17","author":"Z Stachowiak","year":"2023","unstructured":"Stachowiak Z, Wojsyk-Banaszak I, Jo\u0144czyk-Potoczna K et al (2023) Extracellular vesicles-derived MiRNAs as mediators of pulmonary exacerbation in pediatric cystic fibrosis. J Breath Res 17:026005. https:\/\/doi.org\/10.1088\/1752-7163\/acb792","journal-title":"J Breath Res"},{"key":"190_CR64","doi-asserted-by":"publisher","unstructured":"Jadamba B, Jin Y, Lee H (2024) Harmonising cellular conversations: decoding the vital roles of extracellular vesicles in respiratory system intercellular communications. Eur Respir Rev 33. https:\/\/doi.org\/10.1183\/16000617.0272-2023","DOI":"10.1183\/16000617.0272-2023"},{"key":"190_CR65","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","volume":"14","author":"AM Cantin","year":"2015","unstructured":"Cantin AM, Hartl D, Konstan MW, Chmiel JF (2015) Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. J Cyst Fibros 14:419\u2013430. https:\/\/doi.org\/10.1016\/j.jcf.2015.03.003","journal-title":"J Cyst Fibros"},{"key":"190_CR66","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4331\/wjbc.v11.i2.30","volume":"11","author":"I Gopallawa","year":"2020","unstructured":"Gopallawa I, Lee RJ (2020) Targeting the phosphoinositide-3-kinase\/protein kinase B pathway in airway innate immunity. World J Biol Chem 11:30\u201351. https:\/\/doi.org\/10.4331\/wjbc.v11.i2.30","journal-title":"World J Biol Chem"},{"key":"190_CR67","doi-asserted-by":"publisher","first-page":"1081015","DOI":"10.3389\/fphar.2023.1081015","volume":"14","author":"YM Soto-V\u00e1zquez","year":"2023","unstructured":"Soto-V\u00e1zquez YM, Genschmer KR (2023) Impact of extracellular vesicles on the pathogenesis, diagnosis, and potential therapy in cardiopulmonary disease. Front Pharmacol 14:1081015. https:\/\/doi.org\/10.3389\/fphar.2023.1081015","journal-title":"Front Pharmacol"},{"key":"190_CR68","doi-asserted-by":"publisher","unstructured":"Abreu SC, Lopes-Pacheco M, Weiss DJ, Rocco PRM (2021) Mesenchymal stromal Cell-Derived extracellular vesicles in lung diseases: current status and perspectives. Front Cell Dev Biol 9. https:\/\/doi.org\/10.3389\/fcell.2021.600711","DOI":"10.3389\/fcell.2021.600711"},{"key":"190_CR69","doi-asserted-by":"publisher","first-page":"745326","DOI":"10.3389\/fimmu.2021.745326","volume":"12","author":"SL Tucker","year":"2021","unstructured":"Tucker SL, Sarr D, Rada B (2021) Granulocytic Myeloid-Derived suppressor cells in cystic fibrosis. Front Immunol 12:745326. https:\/\/doi.org\/10.3389\/fimmu.2021.745326","journal-title":"Front Immunol"},{"key":"190_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12890-022-01977-1","volume":"22","author":"T Trojan","year":"2022","unstructured":"Trojan T, Alejandre Alcazar MA, Fink G et al (2022) The effect of TGF-\u03b21 polymorphisms on pulmonary disease progression in patients with cystic fibrosis. BMC Pulm Med 22:183. https:\/\/doi.org\/10.1186\/s12890-022-01977-1","journal-title":"BMC Pulm Med"},{"key":"190_CR71","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.4049\/jimmunol.2100424","volume":"207","author":"CM Bojanowski","year":"2021","unstructured":"Bojanowski CM, Lu S, Kolls JK (2021) Mucosal immunity in cystic fibrosis. J Immunol 207:2901\u20132912. https:\/\/doi.org\/10.4049\/jimmunol.2100424","journal-title":"J Immunol"},{"key":"190_CR72","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.3390\/ijms25073713","volume":"25","author":"ED Hejenkowska","year":"2024","unstructured":"Hejenkowska ED, Yavuz H, Swiatecka-Urban A (2024) Beyond borders of the cell: how extracellular vesicles shape COVID-19 for people with cystic fibrosis. Int J Mol Sci 25:3713. https:\/\/doi.org\/10.3390\/ijms25073713","journal-title":"Int J Mol Sci"},{"key":"190_CR73","doi-asserted-by":"publisher","first-page":"8416763","DOI":"10.1155\/2017\/8416763","volume":"2017","author":"G Pizzino","year":"2017","unstructured":"Pizzino G, Irrera N, Cucinotta M et al (2017) Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev 2017:8416763. https:\/\/doi.org\/10.1155\/2017\/8416763","journal-title":"Oxid Med Cell Longev"},{"key":"190_CR74","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY et al (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol 97:2499\u20132574. https:\/\/doi.org\/10.1007\/s00204-023-03562-9","journal-title":"Arch Toxicol"},{"key":"190_CR75","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/JIR.S275595","volume":"13","author":"J Checa","year":"2020","unstructured":"Checa J, Aran JM (2020) Reactive oxygen species: drivers of physiological and pathological processes. J Inflamm Res 13:1057\u20131073. https:\/\/doi.org\/10.2147\/JIR.S275595","journal-title":"J Inflamm Res"},{"key":"190_CR76","doi-asserted-by":"publisher","unstructured":"Moliteo E, Sciacca M, Palmeri A et al (2022) Cystic fibrosis and oxidative stress: the role of CFTR. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27165324","DOI":"10.3390\/molecules27165324"},{"key":"190_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/ph15020217","volume":"15","author":"M Guerini","year":"2022","unstructured":"Guerini M, Condr\u00f2 G, Friuli V et al (2022) N-acetylcysteine (NAC) and its role in clinical practice management of cystic fibrosis (CF): A review. Pharmaceuticals 15:217. https:\/\/doi.org\/10.3390\/ph15020217","journal-title":"Pharmaceuticals"},{"key":"190_CR78","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3390\/biomedicines11102671","volume":"11","author":"AD Pinzaru","year":"2023","unstructured":"Pinzaru AD, Mihai CM, Chisnoiu T et al (2023) Oxidative stress biomarkers in cystic fibrosis and cystic fibrosis-Related diabetes in children: A literature review. Biomedicines 11:2671. https:\/\/doi.org\/10.3390\/biomedicines11102671","journal-title":"Biomedicines"},{"key":"190_CR79","doi-asserted-by":"publisher","unstructured":"Qi H, Wang Y, Fa S et al (2021) Extracellular vesicles as natural delivery carriers regulate oxidative stress under pathological conditions. Front Bioeng Biotechnol 9. https:\/\/doi.org\/10.3389\/fbioe.2021.752019","DOI":"10.3389\/fbioe.2021.752019"},{"key":"190_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12865-020-00386-5","volume":"21","author":"S Chettimada","year":"2020","unstructured":"Chettimada S, Lorenz DR, Misra V et al (2020) Small RNA sequencing of extracellular vesicles identifies Circulating MiRNAs related to inflammation and oxidative stress in HIV patients. BMC Immunol 21:57. https:\/\/doi.org\/10.1186\/s12865-020-00386-5","journal-title":"BMC Immunol"},{"key":"190_CR81","doi-asserted-by":"publisher","unstructured":"Cechinel LR, Batabyal RA, Blume Corssac G et al (2023) Circulating total extracellular vesicles cargo are associated with Age-Related oxidative stress and susceptibility to cardiovascular diseases: exploratory results from microarray data. https:\/\/doi.org\/10.3390\/biomedicines11112920. Biomedicines 11:","DOI":"10.3390\/biomedicines11112920"},{"key":"190_CR82","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s12276-020-0450-9","volume":"52","author":"J Holtzman","year":"2020","unstructured":"Holtzman J, Lee H (2020) Emerging role of extracellular vesicles in the respiratory system. Exp Mol Med 52:887\u2013895. https:\/\/doi.org\/10.1038\/s12276-020-0450-9","journal-title":"Exp Mol Med"},{"key":"190_CR83","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","volume":"106","author":"P Vader","year":"2016","unstructured":"Vader P, Mol EA, Pasterkamp G, Schiffelers RM (2016) Extracellular vesicles for drug delivery. Adv Drug Deliv Rev 106:148\u2013156. https:\/\/doi.org\/10.1016\/j.addr.2016.02.006","journal-title":"Adv Drug Deliv Rev"},{"key":"190_CR84","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav8521","author":"OPB Wiklander","year":"2019","unstructured":"Wiklander OPB, Brennan M\u00c1, L\u00f6tvall J et al (2019) Advances in therapeutic applications of extracellular vesicles. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aav8521. 11:","journal-title":"Sci Transl Med"},{"key":"190_CR85","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","volume":"35","author":"Y Tian","year":"2014","unstructured":"Tian Y, Li S, Song J et al (2014) A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35:2383\u20132390. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.11.083","journal-title":"Biomaterials"},{"key":"190_CR86","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12575-023-00220-3","volume":"25","author":"L Wang","year":"2023","unstructured":"Wang L, Yu X, Zhou J, Su C (2023) Extracellular vesicles for drug delivery in Cancer treatment. Biol Proced Online 25:28. https:\/\/doi.org\/10.1186\/s12575-023-00220-3","journal-title":"Biol Proced Online"},{"key":"190_CR87","doi-asserted-by":"publisher","first-page":"e52326","DOI":"10.1371\/journal.pone.0052326","volume":"7","author":"G Gonzalez","year":"2012","unstructured":"Gonzalez G, Vituret C, Di Pietro A et al (2012) Microparticle-Mediated transfer of the viral receptors CAR and CD46, and the CFTR channel in a CHO cell model confers new functions to target cells. PLoS ONE 7:e52326. https:\/\/doi.org\/10.1371\/journal.pone.0052326","journal-title":"PLoS ONE"},{"key":"190_CR88","doi-asserted-by":"publisher","unstructured":"Allan KM, Farrow N, Donnelley M et al (2021) Treatment of cystic fibrosis: from Gene- to Cell-Based therapies. Front Pharmacol 12. https:\/\/doi.org\/10.3389\/fphar.2021.639475","DOI":"10.3389\/fphar.2021.639475"},{"key":"190_CR89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.omtm.2020.10.018","volume":"20","author":"TA Scott","year":"2021","unstructured":"Scott TA, O\u2019Meally D, Grepo NA et al (2021) Broadly active zinc finger protein-guided transcriptional activation of HIV-1. Mol Ther Methods Clin Dev 20:18\u201329. https:\/\/doi.org\/10.1016\/j.omtm.2020.10.018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"190_CR90","doi-asserted-by":"publisher","unstructured":"Villamizar O, Waters SA, Scott T et al (2021) Mesenchymal stem cell exosome delivered zinc finger protein activation of cystic fibrosis transmembrane conductance regulator. J Extracell Vesicles 10. https:\/\/doi.org\/10.1002\/jev2.12053","DOI":"10.1002\/jev2.12053"},{"key":"190_CR91","doi-asserted-by":"publisher","unstructured":"Duchesneau P, Waddell TK, Karoubi G (2020) Cell-Based therapeutic approaches for cystic fibrosis. Int J Mol Sci 21. https:\/\/doi.org\/10.3390\/ijms21155219","DOI":"10.3390\/ijms21155219"},{"key":"190_CR92","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cellsig.2018.07.015","volume":"51","author":"A Zulueta","year":"2018","unstructured":"Zulueta A, Colombo M, Peli V et al (2018) Lung mesenchymal stem cells-derived extracellular vesicles attenuate the inflammatory profile of cystic fibrosis epithelial cells. Cell Signal 51:110\u2013118. https:\/\/doi.org\/10.1016\/j.cellsig.2018.07.015","journal-title":"Cell Signal"}],"container-title":["Molecular and Cellular Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-025-00190-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40348-025-00190-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-025-00190-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T06:48:07Z","timestamp":1745218087000},"score":1,"resource":{"primary":{"URL":"https:\/\/molcellped.springeropen.com\/articles\/10.1186\/s40348-025-00190-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1186\/s40348-025-00190-4","relation":{},"ISSN":["2194-7791"],"issn-type":[{"value":"2194-7791","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors consent to the publication of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}